0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Image of JAMA Network Reader promo

Image of JAMA forum logo

Become a subscriber
Topic Image
JAMA offers groundbreaking research and insightful commentary from leaders across the broad spectrum of health care. Subscribe/Learn More >

Latest Content

Twitter Facebook

Follow Us

JAMA

JAMA Cardiology

JAMA Dermatology

JAMA Facial Plastic Surgery

JAMA Internal Medicine

JAMA Neurology

JAMA Oncology

JAMA Ophthalmology

JAMA Otolaryngology–Head & Neck Surgery

JAMA Pediatrics

JAMA Psychiatry

JAMA Surgery

Journal of the American Medical Association
Current Issue >
Please Wait... Processing your request... Please Wait.

Current Highlights

Multimedia from The JAMA Network

JAMA Multimedia > Author Interview >

Author Interview Thumbnail

Drug prices continue to rise in the US. Many solutions have been proposed but few have been implemented. Drs. Janet Woodcock from the FDA and Aaron Kesselheim, author of The High Cost of Prescription Drugs in the United States from the Harvard Medical School discuss the role of brand name drugs and generics and how they influence the cost of pharmaceuticals.

Also see The Cost of US Pharmaceutical Price Reductions: A Financial Simulation Model of R&D Decisions by Thomas A. Abbott and John A. Vernon.

audio player

RELATED ARTICLE:

The High Cost of Prescription Drugs in the United States Origins and Prospects for Reform
JAMA. 2016;316(8):858-871
Aaron S. Kesselheim, MD, JD, MPH; Jerry Avorn, MD; Ameet Sarpatwari, JD, PhD

All Author Interviews >

Physician Jobs